Industry Roundtable (Panel)

Sunday, December 1, 2024 at 12:00 AM (CST) to Friday, December 31, 2027 at 11:59 PM (CST)

On-Demand Video

Part 1 Part 2

Event Details

This presentation was a part of the SOCS Meeting The Challenge Summit: Diversity in Dermatology Clinical Trials held on June 10-11, 2022 in Washington, DC. The length of the course is 60 minutes.

Moderator

Donald A. Glass, II, MD, PhD, FAAD

Immediate Past President, Skin of Color Society; Assistant Professor, Department of Dermatology, University of Texas Southwestern Medical Center

Speakers

Daphne Chan PhD, MHEcon

Head of Dermatology, US Medical Affairs, Janssen Scientific Affairs, LLC

David Chu, MD, PhD, FAAD

Executive Director, Clinical Development, Arcutis Biotherapeutics

Sharon Hanlon

Senior Director, Clinical Trial Engagement & Enrollment, Bristol-Myers Squibb

Lotus Mallbris, MD, PhD, IFAAD

Vice President of Lilly Immunology Development and Medical Affairs, Eli Lilly and Company

Chudy Nduaka, DVM, PhD, DABT

Therapeutic Area Head, Dermatology, AbbVie Medical Affairs, AbbVie

Rhonda Peebles

Head of US Dermatology, UCB, Inc.

Paul J. Rowe, MD, ATSF

Vice President, Head of Global Medical, Immunology – Specialty Care, Sanofi

Janet Wangari-Olivero, PhD

Director, Advanced Research; L’Oréal Research & Innovation

JP York, PhD

Associate Director, Prescription Medical Affairs, Galderma Laboratories LP

Alisar S. Zahr, PhD

Director of Research and Clinical Development, Revision Skincare®